INSUBCONTINENT EXCLUSIVE:
PharmEasy offers health services varying from teleconsultation to radiology testsDigital healthcare platform PharmEasy submitted on
Wednesday for a going public (IPO) of up to Rs 6,250 crore ($842.43 million), ending up being the most recent start-up in the nation to
pursue a domestic stock listing.The business offers health services ranging from teleconsultation to radiology tests to home delivery of
medical items and devices.For the 3 months ended June 30, the proforma gross merchandise worth or the total financial worth of all sales for
the company stood at Rs 3,026 crore.API Holdings Ltd, PharmEasy's parent, might likewise consider an additional concern of equity shares by
means of a personal placement of up to Rs 1,250 crore, the business stated in its draft red herring prospectus outdated Nov
The company counts technology-focused equity capital company Naspers and entities related to international financial investment group CDPQ
and private-equity company TPG among its investors.In a bid to diversify its operations, the firm had gotten Thyrocare Technologies, India's
largest diagnostic test service provider by volumes, in September.PharmEasy's IPO filing came on a day when fashion e-commerce start-up
Nykaa is set to debut on stock exchanges, while fintech platform Paytm closes subscription prior to its debut.Citigroup Global Markets
India, JM Financial Ltd, Kotak Mahindra Capital, Morgan Stanley India and BoFA Securities India are joint bookrunners in API Holdings' IPO.
